Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 644

1.

Epidemiology and clinical characteristics of Clostridium difficile infection in a Korean tertiary hospital.

Kim J, Pai H, Seo MR, Kang JO.

J Korean Med Sci. 2011 Oct;26(10):1258-64. doi: 10.3346/jkms.2011.26.10.1258. Epub 2011 Oct 1.

2.

[Investigation of toxin genes of Clostridium difficile strains isolated from hospitalized patients with diarrhoea at Marmara University Hospital].

Deniz U, Ulger N, Aksu B, Karavuş M, Söyletir G.

Mikrobiyol Bul. 2011 Jan;45(1):1-10. Turkish.

PMID:
21341153
3.

Relapse versus reinfection: recurrent Clostridium difficile infection following treatment with fidaxomicin or vancomycin.

Figueroa I, Johnson S, Sambol SP, Goldstein EJ, Citron DM, Gerding DN.

Clin Infect Dis. 2012 Aug;55 Suppl 2:S104-9. doi: 10.1093/cid/cis357.

4.
5.

Clostridium difficile infection in an Iranian hospital.

Jalali M, Khorvash F, Warriner K, Weese JS.

BMC Res Notes. 2012 Mar 21;5:159. doi: 10.1186/1756-0500-5-159.

6.

Clostridium difficile infection at a medical center in southern Taiwan: incidence, clinical features and prognosis.

Chung CH, Wu CJ, Lee HC, Yan JJ, Chang CM, Lee NY, Chen PL, Lee CC, Hung YP, Ko WC.

J Microbiol Immunol Infect. 2010 Apr;43(2):119-25. doi: 10.1016/S1684-1182(10)60019-9.

7.

A retrospective study of the epidemiology of Clostridium difficile infection at a University Hospital in Japan: genotypic features of the isolates and clinical characteristics of the patients.

Iwashima Y, Nakamura A, Kato H, Kato H, Wakimoto Y, Wakiyama N, Kaji C, Ueda R.

J Infect Chemother. 2010 Oct;16(5):329-33. doi: 10.1007/s10156-010-0066-4. Epub 2010 May 7.

PMID:
20449624
8.
9.

Epidemiology and clinical features of toxigenic culture-confirmed hospital-onset Clostridium difficile infection: a multicentre prospective study in tertiary hospitals of South Korea.

Han SH, Kim H, Lee K, Jeong SJ, Park KH, Song JY, Seo YB, Choi JY, Woo JH, Kim WJ, Kim JM.

J Med Microbiol. 2014 Nov;63(Pt 11):1542-51. doi: 10.1099/jmm.0.070672-0. Epub 2014 Sep 3.

PMID:
25187603
10.

Lack of association of outcomes with treatment duration and microbiologic susceptibility data in Clostridium difficile infections in a non-NAP1/BI/027 setting.

Venugopal AA, Riederer K, Patel SM, Szpunar S, Jahamy H, Valenti S, Shemes SP, Khatib R, Johnson LB.

Scand J Infect Dis. 2012 Apr;44(4):243-9. doi: 10.3109/00365548.2011.631029. Epub 2011 Nov 13.

PMID:
22077148
11.

Changing incidence and clinical manifestations of Clostridium difficile-associated diarrhea detected by combination of glutamate dehydrogenase and toxin assay in Northern Taiwan.

Lee YC, Wang JT, Chen AC, Sheng WH, Chang SC, Chen YC.

J Microbiol Immunol Infect. 2012 Aug;45(4):287-95. doi: 10.1016/j.jmii.2011.12.001. Epub 2011 Dec 29.

12.

Risk factors for Clostridium difficile toxin-positive diarrhea: a population-based prospective case-control study.

Vesteinsdottir I, Gudlaugsdottir S, Einarsdottir R, Kalaitzakis E, Sigurdardottir O, Bjornsson ES.

Eur J Clin Microbiol Infect Dis. 2012 Oct;31(10):2601-10. Epub 2012 Mar 23.

PMID:
22441775
13.

Detection of Clostridium difficile and its toxin A (TcdA) in stool specimens from hospitalised patients.

Wróblewska MM, Swoboda-Kopeć E, Rokosz A, Nurzyńska G, Bednarska A, Luczak M.

Pol J Microbiol. 2005;54(2):111-5.

PMID:
16209104
14.

Clinical and microbiologic characteristics of tcdA-negative variant Clostridium difficile infections.

Kim J, Pai H, Seo MR, Kang JO.

BMC Infect Dis. 2012 May 9;12:109. doi: 10.1186/1471-2334-12-109.

15.

Evaluation of a simultaneous detection kit for the glutamate dehydrogenase antigen and toxin A/B in feces for diagnosis of Clostridium difficile infection.

Kawada M, Annaka M, Kato H, Shibasaki S, Hikosaka K, Mizuno H, Masuda Y, Inamatsu T.

J Infect Chemother. 2011 Dec;17(6):807-11. doi: 10.1007/s10156-011-0267-5. Epub 2011 Jul 2.

PMID:
21725661
16.

High frequency of antibiotic-associated diarrhea due to toxin A-negative, toxin B-positive Clostridium difficile in a hospital in Japan and risk factors for infection.

Komatsu M, Kato H, Aihara M, Shimakawa K, Iwasaki M, Nagasaka Y, Fukuda S, Matsuo S, Arakawa Y, Watanabe M, Iwatani Y.

Eur J Clin Microbiol Infect Dis. 2003 Sep;22(9):525-9. Epub 2003 Aug 21.

PMID:
12938013
17.

[Investigation of the presence of Clostridium difficile in antibiotic associated diarrhea patients by culture and toxin detection methods].

Altindiş M, Usluer S, Ciftçi H, Tunç N, Cetinkaya Z, Aktepe OC.

Mikrobiyol Bul. 2007 Jan;41(1):29-37. Turkish.

PMID:
17427550
18.

Clonal dissemination of a toxin-A-negative/toxin-B-positive Clostridium difficile strain from patients with antibiotic-associated diarrhea in Poland.

Pituch H, van den Braak N, van Leeuwen W, van Belkum A, Martirosian G, Obuch-Woszczatyński P, Łuczak M, Meisel-Mikołajczyk F.

Clin Microbiol Infect. 2001 Aug;7(8):442-6.

19.

C. difficile infection (CDI) in a long-term acute care facility (LTAC).

Goldstein EJ, Polonsky J, Touzani M, Citron DM.

Anaerobe. 2009 Dec;15(6):241-3. doi: 10.1016/j.anaerobe.2009.06.009. Epub 2009 Aug 13.

PMID:
19683064
20.

Risk factors and outcome of PCR-detected Clostridium difficile infection in ileal pouch patients.

Li Y, Qian J, Queener E, Shen B.

Inflamm Bowel Dis. 2013 Feb;19(2):397-403. doi: 10.1097/MIB.0b013e318280fcb9.

PMID:
23328770
Items per page

Supplemental Content

Write to the Help Desk